Skip to main content
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1998 Mar;89(3):328–333. doi: 10.1111/j.1349-7006.1998.tb00566.x

Intrinsic Sensitivity of Tumor Cells to Bleomycin as an Indicator of Tumor Response to Electrochemotherapy

Maja Čemažar 1,, Damijan Miklavčič 2, Gregor Serša 1
PMCID: PMC5921803  PMID: 9600128

Abstract

Electrochemotherapy (ECT) involves the use of locally applied electric pulses to increase delivery of chemotherapeutic drugs into cells in tissues. ECT with bleomycin (BLM) is a very effective local treatment, but different tumors have different response rates to ECT. The aim of our study was to compare the responsiveness of SA‐1 and EAT tumors to BLM and ECT in vitro and in vivo, in order to find possible reasons for the observed difference in response rate. The difference in sensitivity to ECT in vitro between the SA‐1 and EAT cells was 10‐fold and was the same as the difference in sensitivity to chronic BLM exposure, as measured by tetrazolium‐based colorimetric (MTT) assay. This difference in sensitivity between SA‐1 and EAT to ECT was also reflected in tumor cure rate. A six‐times lower dose of BLM was needed to obtain local tumor control in SA‐1 than in EAT tumors. Therefore, we suggest that the difference in sensitivity to BLM and ECT predominantly reflects the difference in intrinsic sensitivity of the cells to BLM.

Keywords: Electrochemotherapy, Bleomycin, Electroporation, Experimental tumor, Mice

Full Text

The Full Text of this article is available as a PDF (80.3 KB).

REFERENCES

  • 1. ) Haskell , C. H.Drugs used in cancer chemotherapy . In“Cancer Treatment ,” ed. Haskell C. H. , pp. 63 – 65 ( 1990. ). WB Saunders Co. [Google Scholar]
  • 2. ) Mir , L. M. , Tounekti , O. and Orlowski , S.Bleomycin: revival of an old drug . Gen. Pharmacol. , 27 , 745 – 748 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 3. ) Sidik , K. and Smerdon , M. J.Bleomycin‐induced DNA damage and repair in human cells permeabilized with lysophosphatidylcholine . Cancer Res. , 50 , 1613 – 1619 ( 1990. ). [PubMed] [Google Scholar]
  • 4. ) Natsugoe , S. , Shimada , M. , Kumanohoso , T. , Tokuda , K. , Baba , M. , Yoshinaka , H. , Fukumoto , T. , Nakamura , K. , Yamada , K. and Nakashima , T.Enhanced efficacy of bleomycin adsorbed on silica particles against lymph node metastasis in patients with esophageal cancer: a pilot study . Surgery , 117 , 636 – 641 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 5. ) Mir , L. M. , Orlowski , S. , Belehradek , J.Jr. , Teissie , J. , Rols , M. P. , Serša , G. , Miklavčič , D. , Gilbert , R. and Heller , R.Biomedical applications of electric pulses with special emphasis on antitumor electrochemotherapy . Bioelectrochem. Bioenerg. , 38 , 203 – 207 ( 1995. ). [Google Scholar]
  • 6. ) Rols , M. P. and Teissie , J.Electropermeabilization of mammalian cells. Quantitative analysis of the phenomenon . Biophys. J. , 58 , 1089 – 1098 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. ) Poddevin , B. , Orlowski , S. , Belehradek , J. , Jr. and Mir , L. M.Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture . Biochem. Pharmacol. , 42 , S67 – S75 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) Belehradek , J. , Jr. , Orlowski , S. , Poddevin , B. , Paoletti , C. and Mir , L. M.Electrochemotherapy of spontaneous mammary tumours in mice . Eur. J. Cancer , 27 , 73 – 76 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Mir , L. M. , Orlowski , S. , Belehradek , J. , Jr. and Paoletti , C.Electrochemotherapy potentiation of antitumor effect of bleomycin by local electric pulses . Eur. J. Cancer , 27 ( 1 ), 68 – 72 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 10. ) Mir , L. M. , Orlowski , S. , Poddevin , B. and Belehradek , J. , Jr.Electrochemotherapy tumor treatment is improved by interleukin‐2 stimulation of the host's defenses . Eur. Cytokine Netw. , 3 , 331 – 334 ( 1992. ). [PubMed] [Google Scholar]
  • 11. ) Okino , M. , Tomie , H. , Kanesada , H. , Marumoto , M. , Esato , K. and Suzuki , H.Optimal electric conditions in electrical impulse chemotherapy . Jpn. J. Cancer Res. , 83 , 1095 – 1101 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. ) Salford , L. G. , Persson , B. R. R. , Brun , A. , Ceberg , C. P. , Kongstad , P. C. and Mir , L. M.A new brain tumour therapy combining bleomycin with in vivo electropermeabilization . Biochem. Biophys. Res. Commun. , 194 , 938 – 943 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Serša , G. , Čemažar , M. , Miklavčič , D. and Mir , L. M.Electrochemotherapy: variable anti‐tumor effect on different tumor models . Bioelectrochem. Bioenerg. , 35 , 23 – 27 ( 1994. ). [Google Scholar]
  • 14. ) Heller , R. , Jaroszeski , M. , Messina , J. , Perrot , R. , van Voorhis , N. , Reintgen , D. and Gilbert , R.Treatment of B16 mouse melanoma with the combination of electropermeabilization and chemotherapy . Bioelectrochem. Bioenerg. , 36 , 83 – 87 ( 1995. ). [Google Scholar]
  • 15. ) Mir , L. M. , Roth , C. , Orlowski , S. , Quintin‐Colonna , F. , Fradelizi , D. , Belehradek , J. , Jr. and Kourilsky , P.Systemic antitumor effects of electrochemotherapy combined with histoincompatible cells secreting interleukin‐2 . J. Immunother. , 17 , 30 – 38 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 16. ) Serša , G. , Čemažar , M. , Šemrov , D. and Miklavčič , D.Changing electrode orientation improves the efficacy of electrochemotherapy on solid tumors in mice . Bioelectrochem. Bioenerg. , 39 , 61 – 66 ( 1996. ). [Google Scholar]
  • 17. ) Serša , G. , Kotnik , V. , Čemažar , M. , Miklavčič , D. and Kotnik , A.Electrochemotherapy with bleomycin in SA‐1 tumor bearing mice—natural resistance and immune responsiveness . Anticancer Drugs , 7 , 785 – 791 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 18. ) Belehradek , M. , Domenge , C. , Luboinski , B. , Orlowski , S. , Belehradek , J. , Jr. and Mir , L. M.Electrochemotherapy, a new antitumor treatment. First clinical phase I–II trial . Cancer , 72 , 3694 – 3700 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 19. ) Rudolf , Z. , Štabuc , B. , Čemažar , M. , Miklavčič , D. , Vodovnik , L. and Serša , G.Electrochemotherapy with bleomycin: the first clinical experience in malignant melanoma patients . Radiol. Oncol. , 29 , 229 – 235 ( 1995. ). [Google Scholar]
  • 20. ) Domenge , C. , Orlowski , S. , Luboinski , B. , DeBaere , T. , Schwaab , G. , Belehradek , J. , Jr. and Mir , L. M.Antitumor electrochemotherapy. New advances in the clinical protocol . Cancer , 77 , 956 – 963 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 21. ) Heller , R. , Jaroszeski , M. , Glass , F. , Messina , J. , Rappaport , D. , DeConti , R. , Fenske , N. A. , Gilbert , R. A. , Mir , L. M. and Reintgen , D. S.Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy . Cancer , 77 , 964 – 971 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 22. ) Dev , S. B. and Hofmann , G. A.Electrochemotherapy—a novel method of cancer treatment . Cancer Treat. Rev. , 20 , 105 – 115 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 23. ) Serša , G. , Čemažar , M. and Miklavčič , D.Antitumor effectiveness of electrochemotherapy with cis‐diamminedichloroplatinum(II) in mice . Cancer Res. , 55 , 3450 – 3455 ( 1995. ). [PubMed] [Google Scholar]
  • 24. ) Čemažar , M. , Miklavčič , D. , Vodovnik , L. , Jarm , T. , Rudolf , Z. , Štabuc , B. , Čufer , T. and Serša , G.Improved therapeutic effect of electrochemotherapy with cisplatin by intratumoral drug administration and changing of electrode orientation for electropermeabilization on EAT tumor model in mice . Radiol. Oncol. , 29 , 121 – 127 ( 1995. ). [Google Scholar]
  • 25. ) Carmichael , J. , DeGraff , W. G. , Gazdar , A. F. , Minna , J. D. and Mitchell , J. B.Evaluation of a tetrazolium‐based semiautomated colorimetric assay: assessment of chemosensitivity testing . Cancer Res. , 47 , 936 – 942 ( 1987. ). [PubMed] [Google Scholar]
  • 26. ) Čemažar , M. , Ihan , A. , Jarm , T. , Miklavčič , D. and Serša , G.Determination of optimal electric pulses amplitude for electropermeabilization of different tumor cell lines in vitro . Eur. J. Physiol. , 421 , R176 ( 1996. ). [Google Scholar]
  • 27. ) Begg , A. C.Principles and practices of the tumor growth delay assay . In“Rodent Tumor Models in Experimental Cancer Therapy ,” ed. Kallman R. F. , pp. 114 – 121 ( 1987. ). Pergamon Press; , New York . [Google Scholar]
  • 28. ) Suit , H. D. , Sedlacek , R. and Thames , H. D. , Jr.Radiation dose‐response assays of tumor control . In“Rodent Tumor Models in Experimental Cancer Therapy ,” ed. Kallman R. F. , pp. 138 – 148 ( 1987. ). Pergamon Press; , New York . [Google Scholar]
  • 29. ) Ferrando , A. A. , Velasco , G. , Campo , E. and Lopez‐Otin , C.Cloning and expression analysis of human bleomycin hydrolase, a cysteine proteinase involved in chemotherapy resistance . Cancer Res. , 56 , 1746 – 1750 ( 1996. ). [PubMed] [Google Scholar]
  • 30. ) Lazo , J. S. , Schisselbauer , J. C. , Herring , G. M. and Kennedy , K. A.Involvement of the cellular vacuolar system with the cytotoxicity of bleomycin like agents . Cancer Commun. , 2 , 81 – 86 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 31. ) Pron , G. , Belehradek , J. , Jr. and Mir , L. M.Identification of a plasma membrane protein that specifically binds bleomycin . Biochem. Biophys. Res. Commun. , 194 , 333 – 337 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 32. ) Urade , M. , Sugi , M. and Miyazaki , T.Establishment of three bleomycin‐resistant human carcinoma cell lines and their cross‐resistance to other antitumor agents . Cancer , 61 , 1501 – 1507 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 33. ) Lazo , J. S. , Braun , I. D. , Labaree , D. C. , Schisselbauer , J. C. , Meandzija , B. , Newman , R. A. and Kennedy , K. A.Characteristics of bleomycin‐resistant phenotypes of human cell sublines and circumvention of bleomycin resistance by liblomycin . Cancer Res. , 49 , 185 – 190 ( 1989. ). [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES